SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-17-042954
Filing Date
2017-02-14
Accepted
2017-02-14 14:30:04
Documents
2
Group Members
ARNOLD L. ORONSKYGILBERT H. KLIMANINTERWEST MANAGEMENT PARTNERS X, LLCKEVAL DESAIKHALED A. NASRPHILIP T. GIANOSW. STEPHEN HOLMES III

Document Format Files

Seq Description Document Type Size
1 SC 13G d347396dsc13g.htm SC 13G 137753
2 EX-99.A d347396dex99a.htm EX-99.A 6201
  Complete submission text file 0001193125-17-042954.txt   145727
Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Subject) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89741 | Film No.: 17607140
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, SUITE 200 MENLO PARK CA 94025
Business Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, SUITE 200 MENLO PARK CA 94025 650-854-8585
INTERWEST PARTNERS X LP (Filed by) CIK: 0001443898 (see all company filings)

IRS No.: 263131621
Type: SC 13G